|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000196526 |
Summary for AFAP1 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000196526 | Gene symbol | AFAP1 |
| Gene name | actin filament associated protein 1 | |
| HGNC | 24017 | |
| Entrez ID | 60312 | |
| Gene type | protein_coding | |
| Synonyms | AFAP1|AFAP-110|AFAP | |
| UniProtAcc | Q8N556 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for AFAP1 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| AFAP1 | 1.67e+03 | -1.73e+00 | 2.99e-01 | -5.79e+00 | 7.10e-09 | 9.45e-08 | BLCA |
| AFAP1 | 1.19e+03 | 2.15e+00 | 4.12e-01 | 5.21e+00 | 1.88e-07 | 1.59e-06 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| AFAP1 | 4.71e+02 | 1.17e+00 | 2.56e-01 | 4.59e+00 | 4.37e-06 | 1.90e-05 | LIHC |
Top |
Sex-biased somatic mutation for AFAP1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for AFAP1 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LIHC | cg03204605 | chr4:7940110 | CGI:chr4:7938836-7940126 | promoter | 2.82e-01 | 3.87e-01 | -3.56e+00 | 3.64e-04 | 1.83e-03 | -1.05e-01 |
| LIHC | cg15957394 | chr4:7940096 | CGI:chr4:7938836-7940126 | promoter | 2.79e-01 | 4.01e-01 | -3.96e+00 | 7.36e-05 | 5.59e-04 | -1.22e-01 |
| KIRP | cg18085176 | chr4:7938213 | CGI:chr4:7938836-7940126 | promoter,gene body | 7.02e-01 | 8.06e-01 | -3.49e+00 | 4.81e-04 | 2.78e-03 | -1.04e-01 |
| ACC | cg10028549 | chr4:7940167 | CGI:chr4:7938836-7940126 | promoter | 5.14e-01 | 7.32e-01 | -3.67e+00 | 2.38e-04 | 1.50e-03 | -2.18e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg18085176 | chr4:7938213 | CGI:chr4:7938836-7940126 | promoter,gene body | 4.79e-01 | 5.91e-01 | -3.50e+00 | 4.63e-04 | 7.86e-04 | -1.12e-01 |
| KIRC | cg19564367 | chr4:7940125 | CGI:chr4:7938836-7940126 | promoter | 1.67e-01 | 2.74e-01 | -5.10e+00 | 3.41e-07 | 1.43e-06 | -1.07e-01 |
| HNSC | cg19564367 | chr4:7940125 | CGI:chr4:7938836-7940126 | promoter | 2.37e-01 | 3.50e-01 | -3.88e+00 | 1.04e-04 | 2.68e-04 | -1.13e-01 |
| HNSC | cg10028549 | chr4:7940167 | CGI:chr4:7938836-7940126 | promoter | 6.10e-01 | 7.23e-01 | -2.74e+00 | 6.13e-03 | 8.45e-03 | -1.12e-01 |
| HNSC | cg19702703 | chr4:7940293 | CGI:chr4:7938836-7940126 | promoter | 5.30e-01 | 6.60e-01 | -3.80e+00 | 1.48e-04 | 3.59e-04 | -1.30e-01 |
| LUSC | cg18085176 | chr4:7938213 | CGI:chr4:7938836-7940126 | promoter,gene body | 4.51e-01 | 6.20e-01 | -2.61e+00 | 8.94e-03 | 1.27e-02 | -1.69e-01 |
| BLCA | cg18085176 | chr4:7938213 | CGI:chr4:7938836-7940126 | promoter,gene body | 5.41e-01 | 3.76e-01 | 2.09e+00 | 3.65e-02 | 3.91e-02 | 1.65e-01 |
| LIHC | cg03204605 | chr4:7940110 | CGI:chr4:7938836-7940126 | promoter | 3.87e-01 | 1.44e-01 | 2.33e+00 | 1.99e-02 | 2.23e-02 | 2.43e-01 |
| LIHC | cg14692106 | chr4:7938662 | CGI:chr4:7938836-7940126 | promoter,gene body | 4.04e-01 | 2.82e-01 | 2.95e+00 | 3.23e-03 | 4.47e-03 | 1.22e-01 |
| CHOL | cg03204605 | chr4:7940110 | CGI:chr4:7938836-7940126 | promoter | 5.37e-02 | 1.77e-01 | -3.17e+00 | 1.52e-03 | 1.07e-02 | -1.23e-01 |
| CHOL | cg20708173 | chr4:7938699 | CGI:chr4:7938836-7940126 | promoter,gene body | 2.47e-01 | 3.86e-01 | -2.58e+00 | 9.87e-03 | 2.15e-02 | -1.39e-01 |
| CHOL | cg15957394 | chr4:7940096 | CGI:chr4:7938836-7940126 | promoter | 1.13e-01 | 2.87e-01 | -3.17e+00 | 1.52e-03 | 1.07e-02 | -1.74e-01 |
| CHOL | cg19564367 | chr4:7940125 | CGI:chr4:7938836-7940126 | promoter | 1.46e-01 | 3.60e-01 | -3.54e+00 | 4.02e-04 | 8.32e-03 | -2.15e-01 |
| CHOL | cg10028549 | chr4:7940167 | CGI:chr4:7938836-7940126 | promoter | 5.07e-01 | 7.04e-01 | -2.06e+00 | 3.90e-02 | 4.26e-02 | -1.98e-01 |
| CHOL | cg19702703 | chr4:7940293 | CGI:chr4:7938836-7940126 | promoter | 5.38e-01 | 6.87e-01 | -2.58e+00 | 9.87e-03 | 2.15e-02 | -1.48e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg18085176 | chr4:7938213 | CGI:chr4:7938836-7940126 | promoter,gene body | 5.55e-01 | 2.86e-01 | 1.09e+01 | 1.36e-27 | 1.50e-26 | 2.69e-01 |
| BRCA | cg25003275 | chr4:7938401 | CGI:chr4:7938836-7940126 | promoter,gene body | 2.30e-01 | 1.25e-01 | 8.80e+00 | 1.34e-18 | 6.45e-18 | 1.05e-01 |
| BRCA | cg20708173 | chr4:7938699 | CGI:chr4:7938836-7940126 | promoter,gene body | 1.86e-01 | 8.06e-02 | 1.09e+01 | 1.75e-27 | 1.91e-26 | 1.06e-01 |
| HNSC | cg18085176 | chr4:7938213 | CGI:chr4:7938836-7940126 | promoter,gene body | 4.70e-01 | 2.65e-01 | 2.57e+00 | 1.02e-02 | 1.88e-02 | 2.05e-01 |
| HNSC | cg25003275 | chr4:7938401 | CGI:chr4:7938836-7940126 | promoter,gene body | 2.26e-01 | 9.37e-02 | 3.20e+00 | 1.37e-03 | 9.17e-03 | 1.32e-01 |
| COAD | cg10028549 | chr4:7940167 | CGI:chr4:7938836-7940126 | promoter | 5.16e-01 | 3.91e-01 | 2.28e+00 | 2.26e-02 | 2.84e-02 | 1.25e-01 |
| KIRP | cg19702703 | chr4:7940293 | CGI:chr4:7938836-7940126 | promoter | 7.29e-01 | 6.11e-01 | 3.53e+00 | 4.15e-04 | 2.35e-03 | 1.17e-01 |
Top |
Exon skipping events with PSI in TCGA for AFAP1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for AFAP1 |
| ∗Please access CAeditome for RNA editing annotation. |
| Landscape of RNA editing events across multiple cancer types. |
 |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| STAD | AFAP1-202 | chr4_7874461_- | 3.82e-01 | 2.44e-01 | 2.66e+00 | 7.77e-03 | 4.96e-02 | 1.39e-01 |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for AFAP1 |
| TFs related to AFAP1. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| PCPG | ZNF334 | AFAP1 | 4.16e+00 | 9.82e-01 | 3.25e+00 | 6.17e-03 | Male-biased |
| PCPG | ZNF418 | AFAP1 | 4.02e+00 | 9.82e-01 | 2.98e+00 | 3.29e-03 | Male-biased |
| SARC | FOXR2 | AFAP1 | 3.96e+00 | 9.80e-01 | 3.17e+00 | 2.43e-03 | Male-biased |
| SARC | POU2F2 | AFAP1 | 4.20e+00 | 9.81e-01 | 3.59e+00 | 7.34e-03 | Male-biased |
| SARC | POU4F2 | AFAP1 | 4.26e+00 | 9.81e-01 | 3.66e+00 | 7.74e-03 | Male-biased |
| SARC | ZNF334 | AFAP1 | 4.25e+00 | 9.88e-01 | 3.34e+00 | 1.29e-03 | Male-biased |
| SARC | ZNF418 | AFAP1 | 4.07e+00 | 9.85e-01 | 2.92e+00 | 3.34e-04 | Male-biased |
| SARC | ZNF79 | AFAP1 | 4.09e+00 | 9.84e-01 | 3.19e+00 | 1.37e-03 | Male-biased |
| AFAP1 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for AFAP1 |
| RBPs related to ES in AFAP1. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| COAD | KHDRBS1 | exon_skip_428344 | 8.72e+00 | 9.90e-01 | 8.32e+00 | 4.47e-03 | Male-biased |
| MESO | KHDRBS1 | exon_skip_428344 | 8.53e+00 | 1.13e-02 | 8.87e+00 | 9.84e-01 | Female-biased |
| AFAP1 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000196526 | AC110597.1,hsa-mir-32,AFAP1 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000196526 | RASSF8-AS1,hsa-mir-582,AFAP1 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000196526 | AL109614.1,hsa-mir-133b,AFAP1 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000196526 | AC048341.1,hsa-mir-133b,AFAP1 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000196526 | MCM3AP-AS1,hsa-mir-133b,AFAP1 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000196526 | AL117339.3,hsa-mir-25,AFAP1 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000196526 | ZNF528-AS1,hsa-mir-485,AFAP1 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000196526 | AL021391.1,hsa-mir-485,AFAP1 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000196526 | Z95331.1,hsa-mir-485,AFAP1 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000196526 | Z92544.1,hsa-mir-485,AFAP1 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000196526 | AC116351.1,hsa-mir-485,AFAP1 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000196526 | FAM225B,hsa-mir-485,AFAP1 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000196526 | AC068790.9,hsa-mir-485,AFAP1 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000196526 | GARS1-DT,hsa-mir-485,AFAP1 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000196526 | AC007066.2,hsa-mir-485,AFAP1 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000196526 | SLX1A-SULT1A3,hsa-mir-485,AFAP1 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000196526 | MCM3AP-AS1,hsa-mir-485,AFAP1 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000196526 | AC232271.1,hsa-mir-485,AFAP1 | Female-specific ceRNA | TCGA-LIHC |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs12331653 | chr4:7488990:C:G | - | 0.257452218245648 | 0.0471923407643767 | SARC | Female-baised eQTL |
| rs177769 | chr4:3662479:A:G | - | -0.103797295501686 | 0.0356604836867414 | BLCA | Female-baised eQTL |
| rs60277933 | chr4:11183055:G:A | - | 0.0780292477438846 | 0.030860220043402 | LUAD | Female-baised eQTL |
| rs10033863 | chr4:11185474:G:T | - | 0.0767325009771979 | 0.0404265357775163 | LUAD | Female-baised eQTL |
| rs28573875 | chr4:11185579:T:C | - | 0.0767325009771979 | 0.0404265357775163 | LUAD | Female-baised eQTL |
| rs11737042 | chr4:10410726:A:G | - | 0.0590673046177263 | 0.0454154262115139 | LUAD | Female-baised eQTL |
| rs1354312 | chr4:5362401:T:C | - | -0.0958718215399455 | 0.0487715051241263 | LUAD | Female-baised eQTL |
| rs61694757 | chr4:11217383:A:G | - | 0.137133862825634 | 0.0195148562670241 | COAD | Female-baised eQTL |
| rs6820323 | chr4:11217043:G:A | - | 0.136098028665991 | 0.0218158391874398 | COAD | Female-baised eQTL |
| rs9995211 | chr4:11217161:G:A | - | 0.136098028665991 | 0.0218158391874398 | COAD | Female-baised eQTL |
| rs6814809 | chr4:11216696:G:A | - | 0.137044880248478 | 0.0229560624751465 | COAD | Female-baised eQTL |
| rs10005511 | chr4:11221005:G:T | - | 0.125177453657084 | 0.0258846429773358 | COAD | Female-baised eQTL |
| rs28563829 | chr4:11221829:T:C | - | 0.125177453657084 | 0.0258846429773358 | COAD | Female-baised eQTL |
| rs10007974 | chr4:11221230:G:A | - | 0.111739363453654 | 0.0344994503484379 | COAD | Female-baised eQTL |
| rs10011467 | chr4:11222525:G:A | - | 0.124169685381113 | 0.0349371660746047 | COAD | Female-baised eQTL |
| rs10470829 | chr4:11222751:G:T | - | 0.123482288780219 | 0.0370928145476853 | COAD | Female-baised eQTL |
| rs7340874 | chr4:11222415:T:C | - | 0.115256333023497 | 0.0482188817715026 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs17770213 | chr4:7895139:T:C | gene | 0.0537514462527157 | 0.0161779358176136 | BLCA | Male-baised eQTL |
| rs62290573 | chr4:7915347:A:G | gene | 0.0526921282598703 | 0.0303896000343643 | BLCA | Male-baised eQTL |
| rs7687428 | chr4:7887760:T:C | gene | 0.0511763893117588 | 0.0352724309628105 | BLCA | Male-baised eQTL |
| rs62288891 | chr4:10173293:G:A | - | 0.0607065949596112 | 0.0385591390750806 | BLCA | Male-baised eQTL |
| rs62289359 | chr4:7895441:C:T | gene | 0.0496103616991788 | 0.0483209642778318 | BLCA | Male-baised eQTL |
| rs7673705 | chr4:5153757:G:A | - | -0.0407320637772217 | 0.038634409514765 | LUAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000196526 |
| CpG Site: cg20312457 | |
| Position to Gene: gene | |
| Male Effect: -0.309751730158493 | |
| Female Effect: - | |
 | Gene ID: ENSG00000196526 |
| CpG Site: cg18400079 | |
| Position to Gene: gene | |
| Male Effect: -0.309751730158493 | |
| Female Effect: - | |
 | Gene ID: ENSG00000196526 |
| CpG Site: cg18085176 | |
| Position to Gene: gene,promoter | |
| Male Effect: -0.136026047152764 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg20312457 | chr4:7811748 | gene | -0.309751730158493 | 6.03225945494349e-05 | -0.3137578733992471 | 5.74393460908591e-06 | KIRP |
| cg18400079 | chr4:7812184 | gene | -0.309751730158493 | 6.03225945494349e-05 | -0.3137578733992471 | 5.74393460908591e-06 | KIRP |
| cg18085176 | chr4:7938213 | gene,promoter | -0.136026047152764 | 1.81061762321827e-05 | -0.35440837068996744 | 5.31848521895642e-08 | LUAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of AFAP1 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
